Bioventus BVS
NASDAQ BVS
$10.99 -0.19 (-1.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Bioventus (BVS) FCF Payout Ratio (2021)

Updated

Bioventus' FCF Payout Ratio was 0.04 in Q4 2021.

Analysis

Bioventus (BVS) FCF Payout Ratio (2021) Analysis & Trends

  • In earlier years, FCF Payout Ratio was 0.36 in FY2020 (+57.3%) and 0.23 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 0.08
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 0.89
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 0.71
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn -
10 Bioventus 942.04 Mn 846.16 Mn 97.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 0.04
API Access

Bioventus FCF Payout Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-payout-ratio&ticker=BVS&period=max&api_key=YOUR_API_KEY